Parenchyma-Preserving resections for small nonfunctioning pancreatic endocrine tumors

Annals of Surgical Oncology

Volumn 17, Issue 6, 2010, Pages 1621-1627

  Falconi, Massimo ^a   Zerbi, Alessandro ^b   Crippa, Stefano ^a   Balzano, Gianpaolo ^b   Boninsegna, Letizia ^a   Capitanio, Vanessa ^b   Bassi, Claudio ^a   Di Carlo, Valerio ^b   Pederzoli, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENUCLEATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE; MALE; MORBIDITY; MORTALITY; PANCREAS FISTULA; PANCREAS ISLET CELL TUMOR; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REOPERATION; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME;

EID: 77954816932     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0949-8     Document Type: Article

References (35)

1. Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumors. Endocr Relat Cancer. 2004;11:1-18.
2. Norton JA. Surgery for primary pancreatic neuroendocrine tumors. J Gastrointest Surg. 2006;10:327-331
3. FalconiM, Plockinger U, Kwekkeboom DJ, et al. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology. 2006;84:196-211.
4. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2009;40:30-40.
5. Dralle H, Krohn SL, Karges W, et al. Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg. 2004;28:1248-1260
6. Park BJ, Alexander HR, Libutti SK, et al. Operative management of islet-cell tumors arising in the head of the pancreas. Surgery. 1998;124:1056-1061
7. Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004;18:947-955
8. Lo CY, Lam KY, Kung AW, et al. Pancreatic insulinomas. A 15- year experience. Arch Surg. 1997;132:926-930
9. Crippa S, Bassi C, Salvia R, et al. Outcomes of pancreatic neoplasms enucleation. Br J Surg. 2007;94:1254-1259
10. de Herder WW, Niederle B, Scoazec JY, et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology. 2006;84:183-188
11. Trucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg. 2006;93:264-275
12. Müller MW, Friess H, Kleeff J, et al. Middle segmental pancreatic resection: an option to treat benign pancreatic body lesions. Ann Surg. 2006;244:909-918
13. Falconi M, Mantovani W, Crippa S, et al. Pancreatic insufficiency after different resections for benign tumours. Br J Surg. 2008; 95:85-91.
14. Crippa S, Bassi C, Warshaw AL, et al. Middle pancreatectomy: indications, operative and long-term results. Ann Surg. 2007;246: 69-76.
15. Aranha GV, Shoup M. Nonstandard pancreatic resections for unusual lesions. Am J Surg. 2005;189:223-228
16. Balzano G, Zerbi A, Veronesi P, Cristallo M, Di Carlo V. Surgical treatment of benign and borderline neoplasms of the pancreatic body. Dig Surg. 2003;20:506-510
17. Kwekkeboom DJ, Krenning EP, Scheidhauer K, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)Inpentetreotide. Neuroendocrinology. 2009;90:184-189
18. O'Toole D, Grossman A, Gross D, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. Neuroendocrinology. 2009;90:194-202.
19. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an International Study Group (ISGPF) definition. Surgery. 2005;138:8-13.
20. Heitz PU, Komminoth P, Perren, A et al. Pancreatic endocrine tumours. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. Lyon: IARC Press; 2004.
21. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401.
22. Pape UF, Jann H, Müller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113:256-265
23. Arnold R, Chen YJ, Costa F, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation. Neuroendocrinology. 2009;90:227-233
24. Iacono C, Bortolasi L, Serio G. Is there a place for central pancreatectomy in pancreatic surgery? J Gastrointestinal Surg. 1998; 2:509-517
25. Warshaw AL, Rattner DW, Fernández-del Castillo C, Z'raggen K. Middle segment pancreatectomy: a novel technique for conserving pancreatic tissue. Arch Surg. 1998;133:327-331
26. Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol. 2009; 6:419-428
27. Tonelli F, Fratini G, Nesi G, et al. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg. 2006;244:61-70.
28. Triponez F, Goudet P, Dosseh D, et al. Is surgery beneficial for MEN1 patients with small (\ or =2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg. 2006;30:654-662
29. Gauger PG, Doherty GM, Broome JT, Miller BS, Thompson NW. Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery. 2009;146:801-806
30. Balzano G, Zerbi A, Capretti G, et al. Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg. 2008; 95:357-362
31. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349:2117-2127
32. Solorzano CC, Lee JE, Pisters PW, et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery. 2001;130:1078-1085
33. Vilar E, Salazar R, Pérez-García J, et al. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer. 2007;14:221-232
34. Ferrone CR, Tang LH, Tomlinson J, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol. 2007;25: 5609-5615
35. Reber HA. Middle pancreatectomy: why I rarely do it. J Gastrointest Surg. 2007;11:726-729 Parenchyma-Sparing Resections for NF-PETs